Dr. Kirsten M. Leu
Claim this profileNebraska Methodist Hospital
Studies Breast Cancer
Studies Cancer
12 reported clinical trials
30 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
ER negative
2Cancer
HER2 positive
ER positive
Stage IV
Affiliated Hospitals
Clinical Trials Kirsten M. Leu is currently running
Cemiplimab + Palbociclib
for Liposarcoma
This phase II trial compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with dedifferentiated liposarcoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Palbociclib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Cemiplimab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. The combination of these two drugs may be more effective in shrinking or stabilizing advanced dedifferentiated liposarcoma compared to palbociclib alone.
Recruiting1 award Phase 2
INBRX-109
for Chondrosarcoma
This trial tests INBRX-109, a specially designed protein, in patients with a hard-to-treat type of bone cancer. The treatment helps the immune system target and kill cancer cells by attaching to a specific marker on these cells.
Recruiting0 awards Phase 26 criteria
More about Kirsten M. Leu
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Kirsten M. Leu has experience with
- Paclitaxel
- Radiation Therapy
- Olaparib
- MGC018
- MGA012
- INBRX-109
Breakdown of trials Kirsten M. Leu has run
Breast Cancer
Cancer
Soft Tissue Sarcoma
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kirsten M. Leu specialize in?
Kirsten M. Leu focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Kirsten M. Leu currently recruiting for clinical trials?
Yes, Kirsten M. Leu is currently recruiting for 5 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Kirsten M. Leu has studied deeply?
Yes, Kirsten M. Leu has studied treatments such as Paclitaxel, Radiation Therapy, Olaparib.
What is the best way to schedule an appointment with Kirsten M. Leu?
Apply for one of the trials that Kirsten M. Leu is conducting.
What is the office address of Kirsten M. Leu?
The office of Kirsten M. Leu is located at: Nebraska Methodist Hospital, Omaha, Nebraska 68114 United States. This is the address for their practice at the Nebraska Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.